Endocrine function in patients with untreated chromophobe adenomas.
D000238:Adenoma, Chromophobe / Q000503:physiopathology*; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D000368:Aged; D003397:Craniopharyngioma / Q000503:physiopathology*; D005260:Female; D005951:Glucose Tolerance Test; D006062:Gonadotropins / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007018:Hypopituitarism / Q000503:physiopathology; D007455:Iodine / Q000378:metabolism; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000378:metabolism; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000503:physiopathology*; D010912:Pituitary-Adrenal Function Tests; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000378:metabolism; D014667:Vasopressins / Q000378:metabolism; D014882:Water-Electrolyte Balance
D006062:Gonadotropins; D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D009074:Melanocyte-Stimulating Hormones; D007455:Iodine; D006854:Hydrocortisone